UK-5099 - CAS# 56396-35-1 size:2mg solid DAPT was orally dosed to

DAPT was orally dosed to mice at 100-200 mg/kg once per day or intraperitoneally dosed to mice at 10-100 mg/kg once per day

PubMed PMID: 25775813

Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance

ion channels and transporters

revealing a role for TGFβ signaling mechanism as a repressor of cardiomyocyte fate

UK-5099 - CAS# 56396-35-1 size:2mg solid DAPT was orally dosed toUK 5099, CAS No. 56396 35 1, is a specific and potent mitochondrial pyruvate carrier blocker (MCK blocker). The UK5099 treated cells showed significantly higher proportion of side population (SP) fraction and expressed higher levels of stemness markers Oct3 4 and Nanog. Chemosensitivity examinations revealed that the UK5099 treated cells became more resistant to chemotherapy compared to the non treated cells. MPC blocker (UK5099) application may be an